市場調查報告書

大麻二醇的全球市場 (2020-2027年)

Global Cannabidiol Market - 2020-2027

出版商 DataM Intelligence 商品編碼 968979
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
大麻二醇的全球市場 (2020-2027年) Global Cannabidiol Market - 2020-2027
出版日期: 2020年11月04日內容資訊: 英文
簡介

全球大麻二醇需求源於對多種醫學應用的需求不斷增長,例如緩解壓力,預防糖尿病,緩解疼痛,治療焦慮和抑鬱以及減少痤瘡。隨著全球老年人口的快速增長,癌症,焦慮症和抑鬱症的患病率上升,正在推動全球大麻酚市場的發展。

本報告提供全球大麻二醇市場相關調查,提供市場概要,各市場區隔及地區別的市場分析與預測,競爭情形分析,並提供主要企業簡介等資訊。

目錄

第1章 全球大麻二醇市場:調查手法·範圍

  • 調查手法
  • 調查目的·調查範圍

第2章 全球大麻二醇市場:市場定義和概要

第3章 全球大麻二醇市場:摘要整理

  • 市場明細:各類型
  • 市場明細:各原料
  • 市場明細:各等級
  • 市場明細:各應用領域
  • 市場明細:各流通管道
  • 市場明細:各地區

第4章 全球大麻二醇市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 隨著對幾個政府的藥用CBD的栽培的許可的增加FDA的認證增加
    • 影響分析

第5章 全球大麻二醇市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析

第6章 全球大麻二醇市場:COVID-19分析

  • 市場上Covid-19分析
    • COVID-19:前的市場方案前
    • COVID-19:目前市場方案
    • COVID-19:以後或未來方案
  • Covid-19的價格動態
  • 需求與供給的頻譜
  • 疫情期間與市場有關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球大麻二醇市場:各類型

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各類型
  • 各類型的市場魅力指數:各類型
    • 隔離群
    • 全頻譜
    • 廣頻譜
    • 其他

第8章 全球大麻二醇市場:各原料

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%)
  • 市場魅力指數
    • 大麻
    • Hemp

第9章 全球大麻二醇市場:各等級

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各等級
  • 市場魅力指數:各等級
    • 治療等級
    • 臨床等級
    • 食品等級

第10章 全球大麻二醇市場:各應用領域

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各應用領域
  • 各市場區隔的市場魅力指數:各應用領域
    • 醫藥品
    • 食品和飲料
    • 個人保養品&化妝品
    • 其他

第11章 全球大麻二醇市場:各流通管道

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各流通管道
  • 市場魅力指數:各流通管道
    • 零售藥局
    • 醫院藥局
    • 網路商店
    • 其他

第12章 全球大麻二醇市場-各地區

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析(%):各地區
  • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%):各類型
    • 市場規模分析,及與前一年同期比較成長分析(%):各原料
    • 市場規模分析,及與前一年同期比較成長分析(%):各等級
    • 市場規模分析,及與前一年同期比較成長分析(%):各應用領域
    • 市場規模分析,及與前一年同期比較成長分析(%):各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第13章 全球大麻二醇市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • 合併和收購分析

第14章 全球大麻二醇市場-企業簡介概要

  • ENDOCA
    • 企業概要
    • 組合·說明
    • 主要的焦點
    • 財務概要
  • Cannoid LLC
  • Isodiol International Inc.
  • Elixinol
  • Aurora Cannabis Inc.
  • Pharmahemp d.o.o
  • Medical Marijuana Inc.
  • Folium Biosciences
  • NuLeaf Naturals LLC
  • Aphria Inc.
  • Canopy Growth Corp.

第15章 全球大麻二醇市場:重要考察

第16章 全球大麻二醇市場:DataM

目錄

Market Overview

The global cannabidiol market size was worth US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Cannabidiol is the chemical extracted from the cannabis plants such as hemp and marijuana. It has several health benefits such as alleviate cancer related symptoms, treats skin disease, helps to reduce the blood pressure and reduces inflammation & pain. Cannabidiol has over 80 chemicals, in the cannabis sativa plant while delta-9-tetrahydrocannabinol (THC) is the major active ingredient in cannabidiol.

Since cannabidiol has been studied as effective for making new drugs for several diseases to provide therapeutic treatments. Cannabidiol can only be included in "cosmetic" products and only if it contains less than 0.3% THC. Cannabidiol derived products are mostly used for seizure disorder anxiety, pain, a muscle disorder called dystonia, Parkinson disease, Crohn disease, and many other conditions.

Market Dynamics

The global cannabidiol is driven by rising demand for several medical applications such as stress relief, diabetes prevention, and alleviation of cancer symptoms mitigation of pain, treatment of anxiety and depression, and acne reduction.

Rising prevelence of the cancer, anxiety and depression disorder with surge in the global geriatric population

The market is driven by rising demand prevelence of the cancer, anxiety and depression disorder with surge in the global geriatric population. According to the World Health Organization in 2018, global cancer disease cases have been reached to around 18.1 million new cases and 9.6 million deaths. It created massive demand for the CBD to alleviate the symptoms of cancer disease and provide suitable treatent with the help of CBD bassed drugs an medicines.

Rising prevalence of the chronic diseases such as diabetes, parkinsons, anxiety etc with surge in the geriatric population

Increase in the adoption of the cannabidiol for treatment of the chronic ailments such as diabetes, parkinsons diseases as well as anxiety disorder. According to the International Diabetes Federation in 2019, approximately 463 million people between age 20-79 years are suffering from diabetes globally ans is projected to increase 700 million by 2045. It created massive demand for the medicines made from CBD to cure and prevent the prevelence of diabetes.

Rising FDA approval for the medicines based on CBD for providing treatment for various diseases

Rising FDA approvals with growing permission for the cultivation of CBD for medicinal use by several government may create huge opportunity for the CBD market. For instance on 31st July 2020, the U.S. Food and Drug Administration has approved oral solution called Epidiolex for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients.

Strict rules and regulations with several FDA and government approvals regarding sell of the CBD based products

The global CBD market is hampered by the strict rules and regulations with FDA autharity for the sell of CBD based products. For instance on 15th Nov 2019, the United Staes FDA has warned to around 15 companies for illegally selling various products which contains cannabidiol as due to violations of the safety concerns. Violations include adding CBD to human, animal foods, unapproved new human and animal drugs, selling CBD products as dietary supplements.

COVID-19 Impact Analysis

The global cannabidiol market has received immense impetus from the COVID-19 pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by several chronic ailments such as diabetes, cancer, etc. Increasing research and development is being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for the Cannabidiol products manufacturer, hence, expected to boost the market growth over the forecast period.

Segment Analysis

The global cannabidiol market is segmented based on types, source, grade, application, distribution channel and region.

Isolate segment accounted for the largest share of the global Cannabidiols market in 2019

In terms of type, the global cannabidiol market is bifurcated into isolate, full spectrum, broad spectrum and others. Among this, isolate cannabidiol segment has the highest market share in 2019, this is primarily due to its demand for boosting immune system, fighting against inflammation, prevents vomiting, recover nervous system etc. Several leading players are launching isolate CBD based products to boost the immune system during the covid-19 pandemic. For instance on 20th May 2020, Medterra the leading CBD brand launched its new immune system boosting drops to support a healthy immune system, creating the optimum wellness product.

Similarly, full spectrum and broad spectrum segment has the highest market share in 2019, this is due to rising the adoption of CBD for manufacturing of the cosmetics and personal care products.

Rising prevelence of the elepsy with surge in FDA approval for merijuana based products for providing treatment

Rising prevelence of elepsy disorder with surge in the use of marijuana for manufacturing of phrmacetical drugs to provide the treatment. Several leading players are launching the merijuana based product for providing elepsy treatment due to rissing number of elepsy cases around the globe. According to the World Health Organization in 2019, globally the elepsy cases increased to around 50 million due to which it becomes the most common neurological diseases. It created assive demand for the merijuana segment for providing specific treatment.

Rising product launch, merger and acquisition activities for the development of CBD based products

Based on the grade, the global cannabidiol market is divided into therapeutic grade, clinical grade and food grade. Among this therapeutic grade segment has the highest market share in 2019, owing to rising launching and collaboration activities for the development of therapeutic grade CBD contained product.

For instance on 8th Oct 2020, Marijuana Company of America Inc. has entered into a collaboration and mutual strategic investment with Cannabis Global, Inc for developing of hempSMART products. Further on 23rd Sept 2019, the European Union has approved medicinal cannabis product which aimed at patients with two rare forms of childhood epilepsy. Similarly, clinical grade and food grade segment has the highest share in 2019, this is due to rising adoption of the CBD based products for the manufacturing of the food grade items.

Rising research and development for the development of the pharmaceticle products

Depending on application, global cannabidiol market is divided into pharmaceutical, food & beverages, personal care & cosmetics and others. Among this, pharmaceutical segment has the highest market share in 2019, due to rising R&D spending for the development and launching of the CBD based drugs and medicines. For instance on 6th July, 2020, United States consumers have spent around US$3 billion on CBD Products in 2020. Further pharmaceutical market spending reached to around US$ 1,430 billion in 2020.

Retail pharmacies are expected to dominate the global cannabidiol market during the forecast period.

On the basis of distribution channel, the global cannabidiol is divided into retail pharmacies, hospital pharmacies, online stores and others. Among this, retail pharmacies has the highest market share in 2019, this is due to increasing opening of the retail outlets in several countries, For instance in India on 14th June 2019, Medlife has planned to to open 750 retail pharmacies stores by 2020 end.

Similarly, hospital pharmacies, online stores segments are also growing at faster pace owing to rising demand for trend of online pharmaceticla drug delivery platforms due to Covid-19 pandemic all over the world. For instance on 14th Aug 2020, Amazon launched online pharmacy in India to facilitate medicines to the Indian consumers.

Geographical Analysis

North America region holds the largest market share global Cannabidiol market

North America region is dominating the global cannabidiol market accounted for the largest market share in 2019, due to presence of the leading healthcare companies and rising approval for the CBD based products with presence of permission for cultivation of the marijuana and hemp plants which contribute to create high demand for CBD market in this region followed by Europe. For instance, as per the Frontier Organization report, the United States, consumer spending on legal cannabis cultivation to exceeded to around US$18 billion with increased by 25% in 2020.

It created massive demand for the CBD market in this region for manufacturing, development of the CBD based products. As per the Hemp Industries Association (HIA) report in 2016, retail sales of CBD based products in the United States registered to approximately US $700 million. As per the U.S. Department of Agriculture (USDA) in Canada, the aggregate 225,000 acres of land has cultivation of hemp. Similarly, Asia-Pacific region is fastest growing region for the growth of the CBD based product owing to presence of huge population and growing demand for the medicines for the chronic disorder treatment.

Competitive Landscape

The Cannabidiol market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include ENDOCA, Cannoid LLC, Isodiol International Inc., Elixinol, Aurora Cannabis Inc., Pharmahemp d.o.o, Medical Marijuana Inc., Folium Biosciences, NuLeaf Naturals LLC, Aphria Inc., Canopy Growth Corp and among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the cannabidiol market globally. For instance, on 23rd March 2020, Mota Ventures Corp launched CBD line pure herbal product which contains CBD, and vitamins B3, B12, and C with zinc.

Rising demand FDA approvals with surge in several government approvals for the CBD based products. For instance in October 2019, the Health Ministry of Canada has introduced new regulations to legalize the sale of cannabis-based edibles, beverages, topicals and extracts products. It created massive demand for the cannabidiol market in this region.

Elixinol

Overview: Elixinol, founded in 2014 with the U.S. office based in Westminster, Colorado, United States. Elixinol is the global leading manufacturer of CBD based products with expertise from extraction, processing, growing to formulating products. The Company has diversified product portfolio in healthcare which includes supplements, health, alternative medicine, wellness, organic, health and wellness, sales, marketing, science, contracts, CBD, and hemp.

Product Portfolio: The company has a diverse product portfolio of cannabidiol including:

  • CBD Oils: CBD oil is 100% hemp extract blended with MCT coconut oil and other complimentary ingredients to boost delivery and efficacy. CBD oil has wide range of offerings which includes both full-spectrum and broad-spectrum oils, liposomal oil, as well as USDA certified organic hemp extract. All CBD oils provided by the company are vegan, gluten-free with zero harsh solvents or toxic chemicals.
  • CBD Capsules: CBD capsules, made with high-potency, non-GMO organic hemp. CBD based capsules are used for the treatment of inflammation and antioxidant support and to provide body comfort from stress. All of capsules are 100% vegan, cruelty-free and free of synthetic colors and fragrances.
  • CBD Topicals: CBD topicals, made with 100% organic hemp, are cruelty-free, 100% plant-based, non-GMO and vegan. It contains skin loving ingredients such as capsaicin, copaiba and essential oils to enhance the skin health. CBD gels and balms are great for all skin types and perfect for or providing more localized comfort.

Key Development: In March 2018, Elixinol launched CBD based extra-strength hemp balm for strong, fast-acting muscle relief for athletes. Further on 23rd Jan 2019, Elixinol Hemp CBD Brand launched in New Zealand for offering comprehensive benefits of wide range of cannabidiol (CBD) products to the NZ public on a prescription basis.

Why Purchase the Report?

  • Visualize the composition of the Cannabidiol market segmentation by product, technology, and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in Cannabidiol market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Cannabidiol market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global Cannabidiol market report would provide an access to an approx. 61 market data table, 58 figures and 230 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Cannabidiol Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Cannabidiol Market - Market Definition and Overview

3. Global Cannabidiol Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Source
  • 3.3. Market Snippet by Grade
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by Distribution Channel
  • 3.6. Market Snippet by Region

4. Global Cannabidiol Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing demand for several medical applications such as stress relief, diabetes prevention, alleviation of cancer symptoms mitigation of pain, treatment of anxiety and depression, and acne reduction
      • 4.1.1.2. Increasing prevalence of the chronic diseases with surge in the geriatric population
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Regulatory issues regarding the use of CBD due to its adverse use
      • 4.1.2.2. Legalization and need permission for use of CBD
      • 4.1.2.3. XX
    • 4.1.3. Opportunity
    • 4.1.4. Rising FDA approvals with growing permission for the cultivation of CBD for medicinal use by several government
    • 4.1.5. Impact Analysis

5. Global Cannabidiol Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. Global Cannabidiol Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Cannabidiol Market - By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Isolate*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Full Spectrum
    • 7.3.3. Broad spectrum
    • 7.3.4. Others

8. Global Cannabidiol Market - By Source

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Marijuana*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Hemp

9. Global Cannabidiol Market - By Grade

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  • 9.3. Market Attractiveness Index, By Grade Segment
    • 9.3.1. Therapeutic Grade*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.3.2. Clinical Grade
    • 9.3.3. Food Grade

10. Global Cannabidiol Market - By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3. Market Attractiveness Index, By Application Segment
    • 10.3.1. Pharmaceutical*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 10.3.2. Food & Beverages
    • 10.3.3. Personal Care & Cosmetics
    • 10.3.4. Others

11. Global Cannabidiol Market - By Distribution Channel

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.3. Market Attractiveness Index, By Distribution Channel Segment
    • 11.3.1. Retail Pharmacies*
      • 11.3.1.1. Introduction
      • 11.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 11.3.2. Hospital Pharmacies
    • 11.3.3. Online Stores
    • 11.3.4. Others

12. Global Cannabidiol Market - By Region

  • 12.1. Introduction
  • 12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 12.3. Market Attractiveness Index, By Region
  • 12.4. North America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. U.S.
      • 12.4.8.2. Canada
      • 12.4.8.3. Mexico
  • 12.5. Europe
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. Germany
      • 12.5.8.2. U.K.
      • 12.5.8.3. France
      • 12.5.8.4. Italy
      • 12.5.8.5. Spain
      • 12.5.8.6. Rest of Europe
  • 12.6. South America
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.6.8.1. Brazil
      • 12.6.8.2. Argentina
      • 12.6.8.3. Rest of South America
  • 12.7. Asia Pacific
    • 12.7.1. Introduction
    • 12.7.2. Key Region-Specific Dynamics
    • 12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
    • 12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.7.8.1. China
      • 12.7.8.2. India
      • 12.7.8.3. Japan
      • 12.7.8.4. Australia
      • 12.7.8.5. Rest of Asia Pacific
  • 12.8. Middle East and Africa
    • 12.8.1. Introduction
    • 12.8.2. Key Region-Specific Dynamics
    • 12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
    • 12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Global Cannabidiol Market - Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Global Cannabidiol Market- Company Profiles

  • 14.1. ENDOCA*
    • 14.1.1. Company Overview
    • 14.1.2. Type Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Cannoid LLC
  • 14.3. Isodiol International Inc.
  • 14.4. Elixinol
  • 14.5. Aurora Cannabis Inc.
  • 14.6. Pharmahemp d.o.o
  • 14.7. Medical Marijuana Inc.
  • 14.8. Folium Biosciences
  • 14.9. NuLeaf Naturals LLC
  • 14.10. Aphria Inc.
  • 14.11. Canopy Growth Corp.

LIST NOT EXHAUSTIVE

15. Global Cannabidiol Market - Premium Insights

16. Global Cannabidiol Market - DataM

  • 16.1. Appendix
  • 16.2. About Us and Services
  • 16.3. Contact Us